Biocon Limited (BIOCON.NS)
INR 341.9
(1.65%)
INR 341.9
(1.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 91.73 Billion INR | -24.0% |
| 2022 | 75.11 Billion INR | 41.69% |
| 2021 | 53.01 Billion INR | 11.37% |
| 2020 | 47.59 Billion INR | 14.5% |
| 2019 | 41.57 Billion INR | 19.38% |
| 2018 | 34.82 Billion INR | 48.82% |
| 2017 | 23.39 Billion INR | -2.39% |
| 2016 | 23.97 Billion INR | 15.67% |
| 2015 | 20.72 Billion INR | 15.09% |
| 2014 | 18 Billion INR | 8.31% |
| 2013 | 16.62 Billion INR | 20.47% |
| 2012 | 13.8 Billion INR | 15.42% |
| 2011 | 11.95 Billion INR | 926.38% |
| 2010 | 1.16 Billion INR | -86.53% |
| 2009 | 8.64 Billion INR | 62.16% |
| 2008 | 5.33 Billion INR | 44.7% |
| 2007 | 3.68 Billion INR | -0.9% |
| 2006 | 3.71 Billion INR | 29.46% |
| 2005 | 2.87 Billion INR | -0.45% |
| 2004 | 2.88 Billion INR | 21.23% |
| 2003 | 2.38 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 11.21 Billion INR | -25.86% |
| 2024 Q2 | 23.62 Billion INR | 110.65% |
| 2023 Q4 | 15.12 Billion INR | -34.71% |
| 2023 FY | 57.08 Billion INR | -24.0% |
| 2023 Q1 | 22.13 Billion INR | -13.05% |
| 2023 Q2 | 23.35 Billion INR | 5.53% |
| 2023 Q3 | 23.16 Billion INR | -0.79% |
| 2022 Q3 | 19.61 Billion INR | 25.11% |
| 2022 Q4 | 25.45 Billion INR | 29.75% |
| 2022 Q1 | 14.36 Billion INR | 1.45% |
| 2022 Q2 | 15.67 Billion INR | 9.13% |
| 2022 FY | 75.11 Billion INR | 41.69% |
| 2021 Q4 | 14.16 Billion INR | -3.09% |
| 2021 FY | 53.01 Billion INR | 11.37% |
| 2021 Q1 | 11.48 Billion INR | 2.03% |
| 2021 Q2 | 12.75 Billion INR | 11.04% |
| 2021 Q3 | 14.61 Billion INR | 14.58% |
| 2020 Q1 | 11.29 Billion INR | 32.8% |
| 2020 Q4 | 11.25 Billion INR | -12.81% |
| 2020 Q3 | 12.91 Billion INR | 6.4% |
| 2020 Q2 | 12.13 Billion INR | 7.41% |
| 2020 FY | 47.59 Billion INR | 14.5% |
| 2019 Q3 | 11.7 Billion INR | 6.99% |
| 2019 Q2 | 10.94 Billion INR | 5.08% |
| 2019 FY | 41.57 Billion INR | 19.38% |
| 2019 Q1 | 10.41 Billion INR | 15.03% |
| 2019 Q4 | 8.5 Billion INR | -27.34% |
| 2018 FY | 34.82 Billion INR | 48.82% |
| 2018 Q4 | 9.05 Billion INR | -10.61% |
| 2018 Q3 | 10.12 Billion INR | 15.83% |
| 2018 Q2 | 8.74 Billion INR | 26.73% |
| 2018 Q1 | 6.89 Billion INR | -0.63% |
| 2017 Q2 | 5.91 Billion INR | 4.07% |
| 2017 Q1 | 5.67 Billion INR | -2.54% |
| 2017 Q3 | 6.34 Billion INR | 7.29% |
| 2017 FY | 23.39 Billion INR | -2.39% |
| 2017 Q4 | 6.94 Billion INR | 9.49% |
| 2016 Q2 | 5.86 Billion INR | 0.89% |
| 2016 FY | 23.97 Billion INR | 15.67% |
| 2016 Q1 | 5.81 Billion INR | -4.03% |
| 2016 Q3 | 6.54 Billion INR | 11.59% |
| 2016 Q4 | 5.82 Billion INR | -10.98% |
| 2015 Q4 | 6.05 Billion INR | 17.52% |
| 2015 FY | 20.72 Billion INR | 15.09% |
| 2015 Q2 | 4.98 Billion INR | 10.26% |
| 2015 Q3 | 5.15 Billion INR | 3.34% |
| 2015 Q1 | 4.52 Billion INR | -7.62% |
| 2014 FY | 18 Billion INR | 8.31% |
| 2014 Q3 | 4.43 Billion INR | 0.83% |
| 2014 Q4 | 4.89 Billion INR | 10.44% |
| 2014 Q2 | 4.39 Billion INR | 2.83% |
| 2014 Q1 | 4.27 Billion INR | 0.42% |
| 2013 Q3 | 4.06 Billion INR | -7.47% |
| 2013 FY | 16.62 Billion INR | 20.47% |
| 2013 Q1 | 3.91 Billion INR | 11.32% |
| 2013 Q2 | 4.39 Billion INR | 12.31% |
| 2013 Q4 | 4.25 Billion INR | 4.81% |
| 2012 Q2 | 3.36 Billion INR | 2.54% |
| 2012 FY | 13.8 Billion INR | 15.42% |
| 2012 Q4 | 3.51 Billion INR | -3.29% |
| 2012 Q3 | 3.63 Billion INR | 7.8% |
| 2012 Q1 | 3.28 Billion INR | -5.36% |
| 2011 Q4 | 3.47 Billion INR | 12.7% |
| 2011 Q3 | 3.08 Billion INR | 0.0% |
| 2011 FY | 11.95 Billion INR | 926.38% |
| 2010 FY | 1.16 Billion INR | -86.53% |
| 2009 FY | 8.64 Billion INR | 62.16% |
| 2008 FY | 5.33 Billion INR | 44.7% |
| 2007 FY | 3.68 Billion INR | -0.9% |
| 2006 FY | 3.71 Billion INR | 29.46% |
| 2005 FY | 2.87 Billion INR | -0.45% |
| 2004 FY | 2.88 Billion INR | 21.23% |
| 2003 FY | 2.38 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Blue Jet Healthcare Limited | 3.15 Billion INR | -2803.732% |
| Concord Biotech Limited | 7.56 Billion INR | -1112.708% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | -1770.692% |
| Jubilant Ingrevia Limited | 9.16 Billion INR | -900.824% |
| Lyka Labs Limited | 145.95 Million INR | -62752.856% |
| Panacea Biotec Limited | 1.42 Billion INR | -6325.369% |
| Piramal Pharma Limited | 24.47 Billion INR | -274.874% |
| SMS Lifesciences India Limited | 329.57 Million INR | -27734.248% |
| Supriya Lifescience Limited | 2.65 Billion INR | -3359.348% |
| Syngene International Limited | 12.43 Billion INR | -637.538% |
| TAKE Solutions Limited | 183.42 Million INR | -49913.63% |
| Zota Health Care Limited | 332.52 Million INR | -27487.234% |